Market revenue in 2024 | USD 294.7 million |
Market revenue in 2030 | USD 443.3 million |
Growth rate | 7.1% (CAGR from 2025 to 2030) |
Largest segment | Implantable cardioverter defibrillators |
Fastest growing segment | Ventricular Assist Devices |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Ventricular Assist Devices, Implantable Cardioverter Defibrillators, Pacemakers, Cardiac Resynchronization therapy, Counter Pulsation Devices |
Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Abbott Laboratories, Jarvik Heart, ReliantHeart, Biotronik SE & Co., KG, Berlin Heart GmbH |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to congestive heart failure treatment devices market will help companies and investors design strategic landscapes.
Implantable cardioverter defibrillators was the largest segment with a revenue share of 34.2% in 2024. Horizon Databook has segmented the UK congestive heart failure treatment devices market based on ventricular assist devices, implantable cardioverter defibrillators, pacemakers, cardiac resynchronization therapy, counter pulsation devices covering the revenue growth of each sub-segment from 2018 to 2030.
The rise in geriatric population is a major demographic trend observed in the European Region. A rise in chronic health problems across the aging demographic has increased the demand for solutions related to cardiovascular disorders.
The country has a universal healthcare system wherein majority of the population is covered under free healthcare services offered by the national healthcare centers. As a result, government healthcare facilities are the only target customers for majority of the market players offering cardiac solutions in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the UK congestive heart failure treatment devices market, including forecasts for subscribers. This country databook contains high-level insights into UK congestive heart failure treatment devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account